Ensysce Biosciences, Inc. (ENSC) stock
ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.03 (-6.28%)
Close on Nov 17, 2026Market cap $7.47MP/E –Yield –
Ensysce Biosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Ensysce Biosciences's profit margin for the twelve months ending Sep 30, 2021 was -663.5%. For fiscal 2020 it was 109.7%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | 109.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2021 | Sep 30, 2021 | -1429.3% | −1619.1 |
| Q2 FY2021 | Jun 30, 2021 | -210.5% | −171.9 |
| Q1 FY2021 | Mar 31, 2021 | -683.1% | – |
| Q4 FY2020 | Dec 31, 2020 | 1072.8% | – |
| Q3 FY2020 | Sep 30, 2020 | 189.8% | – |
| Q2 FY2020 | Jun 30, 2020 | -38.6% | – |
See a number that looks wrong?